Aveanna Healthcare (AVAH) Stock Forecast, Price Target & Predictions
AVAH Stock Forecast
Aveanna Healthcare stock forecast is as follows: an average price target of $5.00 (represents a 9.17% upside from AVAH’s last price of $4.58) and a rating consensus of 'Buy', based on 5 wall street analysts offering a 1-year stock forecast.
AVAH Price Target
The average price target for Aveanna Healthcare (AVAH) is $5.00 based on 1-year price targets from 5 Wall Street analysts in the past 3 months, with a price target range of $5.00 to $5.00. This represents a potential 9.17% upside from AVAH's last price of $4.58.
AVAH Analyst Ratings
According to 5 Wall Street analysts, Aveanna Healthcare's rating consensus is 'Buy'. The analyst rating breakdown for AVAH stock is 1 'Strong Buy' (20.00%), 2 'Buy' (40.00%), 2 'Hold' (40.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Aveanna Healthcare Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 09, 2024 | Ben Hendrix | RBC Capital | $5.00 | $4.87 | 2.67% | 9.17% |
| Nov 17, 2022 | Credit Suisse | $2.00 | $0.80 | 149.25% | -56.33% | |
| Aug 19, 2022 | Barclays | $5.00 | $2.13 | 134.74% | 9.17% | |
| Aug 15, 2022 | Raymond James | $6.00 | $2.14 | 180.37% | 31.00% | |
| Jul 12, 2022 | David MacDonald | Truist Financial | $2.50 | $2.49 | 0.40% | -45.41% |
The latest Aveanna Healthcare stock forecast, released on Aug 09, 2024 by Ben Hendrix from RBC Capital, set a price target of $5.00, which represents a 2.67% increase from the stock price at the time of the forecast ($4.87), and a 9.17% increase from AVAH last price ($4.58).
Aveanna Healthcare Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 1 |
| Avg Price Target | - | - | $5.00 |
| Last Closing Price | $4.58 | $4.58 | $4.58 |
| Upside/Downside | -100.00% | -100.00% | 9.17% |
In the current month, the average price target of Aveanna Healthcare stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Aveanna Healthcare's last price of $4.58. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 09, 2024 | Deutsche Bank | Buy | Buy | Hold |
| Aug 09, 2024 | RBC Capital | Sector Perform | Sector Perform | Hold |
| Nov 17, 2022 | Credit Suisse | Neutral | Downgrade | |
| Nov 16, 2022 | Raymond James | Strong Buy | Strong Buy | Hold |
| Aug 19, 2022 | Barclays | Overweight | Overweight | Hold |
| Aug 15, 2022 | Raymond James | Strong Buy | Strong Buy | Hold |
Aveanna Healthcare's last stock rating was published by Deutsche Bank on Aug 09, 2024. The company gave AVAH a "Buy" rating, the same as its previous rate.
Aveanna Healthcare Financial Forecast
Aveanna Healthcare Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $471.94M | $466.41M | $451.15M | $443.01M | $442.95M | $450.53M | - | $411.28M | $436.11M | $417.16M |
| Avg Forecast | $569.90M | $561.00M | $564.30M | $543.90M | $527.36M | $533.21M | $530.78M | $516.53M | $499.47M | $495.87M | $493.49M | $483.98M | $464.99M | $453.69M | $457.57M | $452.03M | $448.16M | $446.78M | $450.62M | $434.33M | $417.33M | $445.79M | $434.01M | $414.39M |
| High Forecast | $573.61M | $564.65M | $567.97M | $547.44M | $530.79M | $536.68M | $534.23M | $518.11M | $502.35M | $495.99M | $493.49M | $484.00M | $474.33M | $453.69M | $460.55M | $454.97M | $451.07M | $446.78M | $450.62M | $434.33M | $417.33M | $445.79M | $434.01M | $414.39M |
| Low Forecast | $566.03M | $557.19M | $560.47M | $540.21M | $523.78M | $529.59M | $527.17M | $514.95M | $495.28M | $495.74M | $493.49M | $483.95M | $459.36M | $453.69M | $454.47M | $448.96M | $445.11M | $446.78M | $450.62M | $434.33M | $417.33M | $445.79M | $434.01M | $414.39M |
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 5 | 6 | 5 | 5 | 5 | 6 | 3 | 3 | 3 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.03% | 1.03% | 1.01% | 0.99% | 0.98% | 1.04% | - | 0.92% | 1.00% | 1.01% |
Aveanna Healthcare's average Quarter revenue forecast for Sep 23 based on 3 analysts is $453.69M, with a low forecast of $453.69M, and a high forecast of $453.69M. AVAH's average Quarter revenue forecast represents a -3.87% decrease compared to the company's last Quarter revenue of $471.94M (Jun 23).
Aveanna Healthcare EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 5 | 6 | 5 | 5 | 5 | 6 | 3 | 3 | 3 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $-102.39M | $-8.09M | $24.37M | $7.56M | $14.29M | $24.27M | $22.48M | - | $20.07M | $31.57M | $36.93M |
| Avg Forecast | $-25.61M | $-25.21M | $-25.36M | $-24.44M | $-23.70M | $-23.96M | $-23.85M | $-23.21M | $-22.44M | $-22.28M | $-22.18M | $42.13M | $-20.90M | $-20.39M | $-20.56M | $38.30M | $10.97K | $28.40M | $28.64M | $34.82M | $26.53M | $28.34M | $27.59M | $31.65M |
| High Forecast | $-25.44M | $-25.04M | $-25.19M | $-24.28M | $-23.54M | $-23.80M | $-23.69M | $-23.14M | $-22.26M | $-22.28M | $-22.18M | $50.56M | $-20.64M | $-20.39M | $-20.42M | $45.96M | $13.17K | $28.40M | $28.64M | $41.78M | $26.53M | $28.34M | $27.59M | $37.99M |
| Low Forecast | $-25.78M | $-25.37M | $-25.52M | $-24.60M | $-23.85M | $-24.12M | $-24.01M | $-23.28M | $-22.57M | $-22.29M | $-22.18M | $33.71M | $-21.32M | $-20.39M | $-20.70M | $30.64M | $8.78K | $28.40M | $28.64M | $27.86M | $26.53M | $28.34M | $27.59M | $25.32M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 5.02% | 0.39% | 0.64% | 689.15% | 0.50% | 0.85% | 0.65% | - | 0.71% | 1.14% | 1.17% |
3 analysts predict AVAH's average Quarter EBITDA for Jun 23 to be $-20.56M, with a high of $-20.42M and a low of $-20.70M. This is -184.36% lower than Aveanna Healthcare's previous annual EBITDA (Mar 23) of $24.37M.
Aveanna Healthcare Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 5 | 6 | 5 | 5 | 5 | 6 | 3 | 3 | 3 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $-102.39M | $25.60M | $-32.00M | $-237.78M | $24.30M | $-473.89M | $25.33M | - | $2.09M | $1.26M | $5.80M |
| Avg Forecast | $13.54M | $11.60M | $11.60M | $11.60M | $5.32M | $5.21M | $5.58M | $1.18M | $-682.18K | $-2.42M | $-3.96M | $6.61M | $-4.82M | $-4.22M | $-7.06M | $6.01M | $-4.12M | $7.25M | $11.51M | $5.47M | $21.94M | $23.23M | $19.98M | $4.97M |
| High Forecast | $13.65M | $11.70M | $11.70M | $11.70M | $5.36M | $5.26M | $5.63M | $10.86M | $13.64M | $-2.40M | $-3.92M | $7.94M | $-2.41M | $-4.18M | $-7.00M | $7.22M | $-4.09M | $7.25M | $11.51M | $6.56M | $21.94M | $23.23M | $19.98M | $5.96M |
| Low Forecast | $13.42M | $11.50M | $11.50M | $11.50M | $5.27M | $5.17M | $5.53M | $-3.96M | $-13.64M | $-2.44M | $-3.99M | $5.29M | $-7.23M | $-4.25M | $-7.12M | $4.81M | $-4.16M | $7.25M | $11.51M | $4.37M | $21.94M | $23.23M | $19.98M | $3.98M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 24.28% | -3.63% | -5.32% | 57.67% | 3.35% | -41.17% | 4.63% | - | 0.09% | 0.06% | 1.17% |
Aveanna Healthcare's average Quarter net income forecast for Sep 23 is $-4.22M, with a range of $-4.25M to $-4.18M. AVAH's average Quarter net income forecast represents a -116.48% decrease compared to the company's last Quarter net income of $25.60M (Jun 23).
Aveanna Healthcare SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 5 | 6 | 5 | 5 | 5 | 6 | 3 | 3 | 3 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $60.77M | $110.68M | $122.76M | $125.20M | $125.31M | - | $114.24M | $110.12M | $96.77M |
| Avg Forecast | $143.50M | $141.25M | $142.09M | $136.95M | $132.78M | $134.26M | $133.64M | $130.06M | $125.76M | $124.85M | $124.26M | $110.40M | $117.08M | $114.24M | $115.21M | $100.37M | $112.84M | $112.50M | $113.46M | $91.24M | $105.08M | $112.25M | $109.28M | $82.95M |
| High Forecast | $144.43M | $142.17M | $143.01M | $137.84M | $133.65M | $135.13M | $134.51M | $130.45M | $126.49M | $124.88M | $124.26M | $132.48M | $119.43M | $114.24M | $115.96M | $120.44M | $113.58M | $112.50M | $113.46M | $109.49M | $105.08M | $112.25M | $109.28M | $99.54M |
| Low Forecast | $142.52M | $140.29M | $141.12M | $136.02M | $131.88M | $133.35M | $132.74M | $129.66M | $124.71M | $124.82M | $124.26M | $88.32M | $115.66M | $114.24M | $114.43M | $80.29M | $112.07M | $112.50M | $113.46M | $72.99M | $105.08M | $112.25M | $109.28M | $66.36M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.61% | 0.98% | 1.09% | 1.10% | 1.37% | - | 1.02% | 1.01% | 1.17% |
Aveanna Healthcare's average Quarter SG&A projection for Jun 23 is $115.21M, based on 3 Wall Street analysts, with a range of $114.43M to $115.96M. The forecast indicates a 89.58% rise compared to AVAH last annual SG&A of $60.77M (Mar 23).
Aveanna Healthcare EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 5 | 6 | 5 | 5 | 5 | 6 | 3 | 3 | 3 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $-0.54 | $0.14 | $-0.17 | $-1.28 | $0.13 | $-2.56 | $0.14 | - | $0.01 | $0.01 | $0.03 |
| Avg Forecast | $0.07 | $0.06 | $0.06 | $0.06 | $0.03 | $0.03 | $0.03 | $0.01 | $-0.00 | $-0.01 | $-0.02 | $-0.05 | $-0.02 | $-0.02 | $-0.04 | $-0.06 | $-0.02 | $0.04 | $0.06 | $0.06 | $0.11 | $0.12 | $0.10 | $0.07 |
| High Forecast | $0.07 | $0.06 | $0.06 | $0.06 | $0.03 | $0.03 | $0.03 | $0.06 | $0.07 | $-0.01 | $-0.02 | $-0.05 | $-0.01 | $-0.02 | $-0.04 | $-0.06 | $-0.02 | $0.04 | $0.06 | $0.06 | $0.11 | $0.12 | $0.10 | $0.07 |
| Low Forecast | $0.07 | $0.06 | $0.06 | $0.06 | $0.03 | $0.03 | $0.03 | $-0.02 | $-0.07 | $-0.01 | $-0.02 | $-0.05 | $-0.04 | $-0.02 | $-0.04 | $-0.06 | $-0.02 | $0.04 | $0.06 | $0.06 | $0.11 | $0.12 | $0.10 | $0.07 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 24.76% | -3.83% | 2.82% | 60.03% | 3.53% | -43.78% | 2.33% | - | 0.08% | 0.07% | 0.44% |
According to 3 Wall Street analysts, Aveanna Healthcare's projected average Quarter EPS for Sep 23 is $-0.02, with a low estimate of $-0.02 and a high estimate of $-0.02. This represents a -115.58% decrease compared to AVAH previous annual EPS of $0.14 (Jun 23).
Aveanna Healthcare Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| SEM | Select Medical | $19.12 | $40.00 | 109.21% | Buy |
| ACHC | Acadia Healthcare Company | $39.64 | $81.50 | 105.60% | Buy |
| INNV | InnovAge | $4.08 | $6.80 | 66.67% | Hold |
| SGRY | Surgery Partners | $21.03 | $35.00 | 66.43% | Buy |
| BKD | Brookdale Senior Living | $5.25 | $8.00 | 52.38% | Buy |
| UHS | Universal Health Services | $182.60 | $249.67 | 36.73% | Hold |
| PNTG | Pennant Group | $29.21 | $34.67 | 18.69% | Buy |
| OPCH | Option Care Health | $23.42 | $27.33 | 16.70% | Buy |
| EHAB | Enhabit | $8.29 | $9.50 | 14.60% | Hold |
| ENSG | Ensign Group | $140.00 | $159.00 | 13.57% | Buy |
| ADUS | Addus HomeCare | $130.73 | $146.20 | 11.83% | Buy |
| EHC | Encompass Health | $96.94 | $107.50 | 10.89% | Buy |
| AVAH | Aveanna Healthcare | $4.78 | $5.00 | 4.60% | Buy |